# Shenzhen Bioeasy Biotechnology

> Shenzhen Bioeasy Biotechnology is a VC fund in Shenzhen backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shenzhen, China
- Total investments: 2
- Last investment: Dec 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/shenzhen-bioeasy
- Website: http://www.bioeasy.net.cn
- Facebook: https://www.facebook.com/shenzhenbioeasy/

Shenzhen Bioeasy Biotechnology is a VC fund in Shenzhen focused on Medical and Health Care. Shenzhen Bioeasy products include rapid test kits and instruments for detection of antibiotics, aflatoxin, pesticides and other food addictive residues, serving clients all over the world in fields like dairy, meat & seafood, feed, grain and oil, food processing etc.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Health Diagnostics | 1 | 50% |
| Supply Chain Management | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Myriad Stars Information Technology | Myriad Star Information Technology focuses on providing services for small and micro medical services. It provides comprehensive services such as medical equipment suppling chains finance and SaaS tools for small and medium hospitals such as pets, dentistry, and community hospitals to upgrade multi-dimensional services including brand, customeracquisition, capital, and technology. |  | Series B | Dec 25, 2025 |  |
| Zhiqin Instruments | Zhiqin Instruments is an instrument supplier that offers full solutions for analysis and testing to important industries based on its own rapid detection mass spectrometer. |  | Series A | Apr 25, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Leaguer Group](https://shizune.co/investors/profile/leaguer-group) — VC Fund, 1 deal together
- Saizhi One — VC Fund, 1 deal together
- [SZHTI Group](https://shizune.co/investors/profile/szhti-group) — VC Fund, 1 deal together
- Zheshang Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Shenzhen Bioeasy Biotechnology invest in?

Shenzhen Bioeasy Biotechnology invests primarily in Medical, Health Care and Health Diagnostics startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shenzhen Bioeasy Biotechnology last invest?

The most recent investment recorded for Shenzhen Bioeasy Biotechnology closed in Dec 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co